Introduction
============

The global increase in multi-resistant ESKAPE pathogens (*Enterococcus faecium*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Enterobacter* species) has created an urgent need to develop replacement therapies. ESKAPE pathogens are responsible for the top 6 health care-associated infections (HAIs) and many have been identified as priority antibiotic-resistant bacteria ([@B21]; [@B41]; [@B14]; [@B47]). Infections with multi-resistant pathogens are extremely hard to treat and may spread throughout a hospital or community environment ([@B21]; [@B41]). It was thought that developing new antibiotics from combinatorial chemistry would be able to eliminate these resistant bacteria. However, years of trials have not produced anything like the number of new drugs necessary to stem the tide of multi-resistant bacteria ([@B28]). In addition, the production of new antibiotics tapered off in the early 1980s due to unfavorable market conditions which has led to a crisis in the supply line of new antibiotics ([@B41]; [@B14]). Normally, bacterial infections are treated with the simplest, most effective antibiotics, however, multi-resistant pathogens usually require treatment with higher tier antibiotics or antibiotics of last resort ([@B41]). There are no guarantees of success with these treatments and they can involve expensive and sometimes toxic chemotherapy. If all solutions fail, infections by ESKAPE pathogens can lead to death of the patient and a spread of multi-resistant strains. Antibacterial resistance has now been detected for nearly all new antibiotics, even those of last resort ([@B22]; [@B29]). As a consequence, the WHO have created an urgent priority list for discovery of new antibiotics ([@B47]).

Current strategies to alleviate the shortage of new antibiotics have turned to niche environments such as deserts, thermal vents, and alkaline environments in the hope that they might produce exotic varieties of current antibiotics ([@B42]; [@B31]; [@B51]; [@B34]). Alkaline environments in particular have proven to be a rich source of antibiotics, many derived from *Streptomyces* bacteria ([@B42]; [@B51]; [@B6]; [@B30]). Together with other members of the phylum Actinobacteria, *Actinomycetes*, are responsible for the synthesis of more than half of modern medicines including antimicrobial, anti-cancerous ([@B38]), antiviral ([@B50]), antifungal ([@B35]), and antiparasitic compounds ([@B40]). In 1943, it was streptomycin (from *Streptomyces*) that was the great savior against the formally incurable scourge of tuberculosis ([@B43]).

Another promising avenue of drug (re)discovery lies in the investigation of traditional medicines or ethnopharmacology. Although ancient medical traditions are well known in Chinese and Native American cultures, less is known about European folk medicines ([@B13]; [@B6]; [@B26]). One of the last vestiges of continuous ethnopharmacological culture can be found on the most westerly fringes of Europe, in rural locations on the island of Ireland ([@B13]). One such cure originates from a region of the West Fermanagh Scarplands known locally as Boho (pronounced Bo) in Northern Ireland. This cure is derived from an alkaline soil deposited in the late Pleistocene period (circa 9,126,000--11,700 years ago) on a bedrock of Carboniferous Dartry limestone (circa 335 million years ago) imparting an alkaline/high radon character to the soil ([@B8]). Traditionally, this cure had been used to treat a variety of conditions from toothache to infections by placing a small portion of the soil wrapped in cloth next to the infection or underneath the users' pillow for 9 days. The soil was then returned to the area of sampling. The exact specificity and origins of the cure are obscured by lack of documentation, however, some relatively recent written records remain, associating it with the grave of James McGirr, a cleric and healer who died in 1815 ([@B15]). Previous to this time the area had significance as an amphitheater for the Druids and a symbolic place for Neolithic peoples as evidenced by the nearby Reyfad stones ([@B17]).

The purpose of this paper is to report the isolation of a novel alkaliphilic strain of *Streptomyces* from soil with antimicrobial activity against multiresistant ESKAPE pathogens which may have potential clinical applications.

Materials and Methods {#s1}
=====================

Sampling
--------

The Boho soil sample was collected from an alkaline escarpment region (Latitude-54.364637°N Longitude-7.820939°W) at the Sacred Heart Church, in the townland of Toneel North, Boho, Fermanagh, United Kingdom ([@B12]) on the 28 July 2015. The test soil, which was pre-aliquoted into small cloth bags on site, was sampled with a sterile spatula. Instructions as to the traditional uses and practices with the soil are displayed on the door of an adjacent building. Approximately 25 g of this soil sample was collected in a sterile conical sample tube (50 ml) and dispatched to the laboratory for analysis. For laboratory analysis, 1 g of the Boho soil sample was diluted in 1 ml sterile water, vortexed, and cultured on International Streptomyces Project (ISP) 2 agar (1/5th strength), and Starch agar (1/5th strength) for the initial *Streptomyces* isolation.

Microorganism Strains
---------------------

*Escherichia coli* (ATCC, K12-MG1655) was provided by Dr. D. Zahradka, Ruđer Bošković Institute (RBI), Zagreb, Croatia.

*Bacillus subtilis* (strain 168) was provided by Dr. D. Vujaklija (RBI, Croatia).

ESKAPE pathogens listed below and other ATCC strains listed were provided by Dr. M. Jelić ([@B21], [@B22]).

*Enterococcus faecium* -- strains: a, b, c (VRE), d, e, and f.

*Staphylococcus aureus* -- strains: a, b (MRSA), c, d, and e (MRSA).

*Klebsiella pneumoniae* -- strains: a, b, c, and d.

*Acinetobacter baumannii* -- strains: a, b, c, d, and e.

*Pseudomonas aeruginosa* -- strains: a, b, c, and ATCC 27853.

*Enterobacter cloacae* -- strain: a.

The ESKAPE pathogens were clinical isolates collected through regular hospital activities. Species identification was performed using standard biochemical methods (tests) and the VITEK 2 system (bioMérieux, France) ([@B21], [@B22]). Isolates were assigned unique isolate IDs and subsequently anonymized with designations a, b, c, etc. (meaning the strains cannot be linked to patients in any identifiable manner) in accordance with European regulations. Stocks of original *Streptomyces* were frozen at -80°C in 18% glycerol after their initial isolation.

Microbiological Media
---------------------

Microbiological media used in these experiments: ISP 2 media (1/5th strength: meaning 20% of standard ingredients except agar which was 2%) and Starch media (1/5th strength) for initial *Streptomyces* isolation. Soy Flour Mannitol (SFM) for *Streptomyces* sub culture and growth. Alkaline SFM for selection of alkaline tolerant *Streptomyces* (soy flour 10 g, mannitol 10 g, agar 20 g, CaCO~3~ 1 g, humic acid 0.002 g, pH adjusted to 8.3 before sterilization). Blood agar was used for the isolation and cultivation of clinical isolates and Mueller-Hinton agar used for antimicrobial tests unless organisms specifically required enriched blood media.

For the determination of *Streptomyces* alkaline tolerance, we used ISP-2 media supplemented with *Streptomyces* minor elements solution \[consisting of 0.1% (wt/vol) (each) of ZnSO~4~⋅7H~2~O, FeSO~4~⋅7H~2~O, MnCl~2~⋅4H~2~O, and CaCl~2~ anhydrous\], 1% (wt/vol) glucose, and 0.02% (vol/vol) NaH~2~PO~4~--K~2~HPO~4~ buffer (0.1 M, pH 6.8). It was necessary to increase the concentration of agar to 4% after pH 13.2, and 6% after 13.4, due to the inability of lower agar concentrations to solidify. The pH of the agar was adjusted after sterilization (when the agar had cooled but was still liquid, i.e., 42--45°C) by the addition of appropriate volumes of filter sterilized sodium carbonate buffer (0.2 M Na~2~CO~3~ + 0.2 M NaH~2~CO~3~; pH 9.2 → 10.7) and potassium chloride/sodium hydroxide buffer (0.2 M KCl + 0.2 M NaOH; pH 11.6 → 13.0). The pH of the agar was checked immediately after the agar had set.

On the occasions when the robust growth of frozen stocks of *Streptomyces* isolates seemed to decline (as was observed from 2-year-old stocks, even when stored in glycerol at -80°C), stocks were revived by cultivation of the *Streptomyces* sp. myrophorea, isolate McG1 on ISP 2 agar (1/5th) supplemented with *Streptomyces* minor elements solution. In some cases, a mineral solution was made from alkaline soil by dissolving 1 g soil in 1 g water, vortexed (1-min), centrifuged (15,616 ×*g*, 10 min) to clear the supernatant and then added at a concentration of 0.5% (vol/vol) to pre-solidified agar. In both cases supplements were filter sterilized (syringe filter, 0.2 μm) prior to their addition to the agar to prevent precipitation of ferric compounds. Cores of this agar were used as negative controls in antimicrobial inhibition assays involving Mueller-Hinton agar. All reagents were supplied by Oxoid (Basingstoke, Hampshire, United Kingdom) except agar which was supplied by Melford (Melford, Suffolk, United Kingdom).

Atomic Force Microscopy
-----------------------

Atomic Force Microscopy (Bruker BioScope Catalyst; Bruker Instruments, Santa Barbara, CA, United States) was used to visualize *Streptomyces* hyphae growing on glass cover slips. The measurements were conducted in air, using TESPA cantilevers (Bruker Instruments, Santa Barbara, CA, United States) in Tapping Mode, with a nominal spring constant of 40 N/m and a nominal resonant frequency of 300 kHz. Off-line processing involved first-order plane fitting and flattening using the software Nan scope Analysis 1.50 (Bruker Instruments, Santa Barbara, CA, United States).

pH Measurement
--------------

Soil pH was measured by dissolving 1 g of soil in 5 ml distilled water, shaking for 5 min and then waiting 1 h for the soil to settle (measuring in triplicate using a pH-meter; Mettler-Toledo Seven Compact, Leicester, United Kingdom). A similar procedure was used with pH paper, where 1 g of soil was dissolved in 2 ml distilled water, vortexed for 15 min, and applied in small aliquots to pH indicator strips (EMD Millipore ColorpHast, Burlington, MA, United States). The pH strips were accurate to 0.5 pH units.

To test the alkaline tolerance of bacteria, a pH gradient was established from pH 9.0 to 13.0 in ISP-2 by adding sterilized buffer as described above. The pH of agar surface was continuously monitored using flat pH sticks (Macherey-Nagel GmbH & Co. KG, Düren, Germany) as described ([@B23]). The pH strip accuracy was routinely tested against standard pH calibration solutions.

Gamma-Irradiation of *Streptomyces* sp. Myrophorea, Isolate McG1 Spores
-----------------------------------------------------------------------

*Streptomyces* sp. myrophorea, isolate McG1 spore concentrations were estimated by cultivation of dilutions of the spore stock. A 1 ml spore suspension (estimated to be 1 × 10^5^ spores/ml) received gamma radiation doses of 0.25, 0.5, 1.0, 2.0, 4.0, 10.0, 15.0, and 20.0 kiloGray (kGy) from a cobalt source (^60^Co, 8.2645 Gy/s). Spore suspensions were contained in 2 ml plastic microfuge tubes surrounded by a layer of ice inside a polystyrene ice container. After irradiation, aliquots of the spore suspensions were spread (100 μl) on SFM agar and cultivated for 2--3 weeks. The growth of one colony (colony-forming units = CFU) was interpreted to be the survival of one spore.

Antimicrobial Tests
-------------------

### Agar Overlay

A standard agar overlay combined with an antibiotic assay was used to test the inhibitory potential of *Streptomyces* sp. myrophorea, isolate McG1 against ESKAPE pathogens ([@B36]; [@B27]). Briefly, wells were made in a base layer (15 ml) of Mueller-Hinton agar. Control wells contained standard amounts of dissolved antibiotics were allowed to absorb into the agar over a period of 2 h. Once the wells were dry, an agar core of *Streptomyces* sp. myrophorea, isolate McG1 (cultivated for 9 days 20°C) was placed in an empty well in addition to a negative control of the original media without *Streptomyces* sp. myrophorea, isolate McG1. This base layer was then overlaid with 15 ml Mueller-Hinton agar (cooled to 43°C) that incorporating the test organisms (ESKAPE pathogens with a minimum 5 × 10^5^ CFU/ml). Bacterial inhibition was indicated by a clear zone in the confluent growth of the test organism after overnight incubation.

Kirby--Bauer
------------

Antibiotic sensitivity tests (antibiograms) for the *Streptomyces* sp. myrophorea, isolate McG1 and for ESKAPE pathogens followed the Kirby--Bauer protocol ([@B5]). The resistance profiles (antibiograms) of clinical isolates (ESKAPE pathogens) were determined using standard concentrations of antibiotic impregnated discs (Oxoid) as proposed by the European Committee on Antimicrobial Susceptibility Tests (EUCAST) (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Breakpoint tables for interpretation of MICs and zone diameters can be found in Version 8.0, 2018^[1](#fn01){ref-type="fn"}^.

Genotypic Characterization of *Streptomyces* sp. Myrophorea, Isolate McG1
-------------------------------------------------------------------------

### Genome Sequencing

Cultures of *Streptomyces* sp. myrophorea, isolate McG1 were grown on 1/10th strength LB agar for DNA extraction using a Qiagen DNA mini kit (Qiagen, MD, United States) with the inclusion of a lysis step using lysozyme. Genomic DNA was prepared for sequencing using Qiagen FX and sequenced on an Illumina MiSeq platform using a 600 cycle V3 reagent kit.

### Assembly and Annotation of Genome

Paired-end reads were subjected to quality filtering using the Trimmomatic tool (4 bp sliding window of Q20) ([@B7]) prior to *de novo* genome assembly using SPAdes under default parameters ([@B4]). The genome assembly was assessed using QUAST ([@B16]) and annotated using Prokka ([@B45]) and Rapid Annotation using Subsystem Technology (RAST)^[2](#fn02){ref-type="fn"}^ ([@B3]).

Phylogenetic Analysis
---------------------

*In silico* DNA--DNA hybridization was performed using the Genome--Genome Distance Calculator (GGDC) v 2.1 ([@B2]) using all *Streptomyces* genomes (868 sequences) as references. All genomes were downloaded from GenBank^[3](#fn03){ref-type="fn"}^.

Phylogenetic placement of *Streptomyces* sp. myrophorea, isolate McG1 was performed using PhyloPhlAn ([@B46]). Protein sequences from annotated *Streptomyces* genomes were retrieved autonomously from the GenBank FTP site using the term "*Streptomyces*" as a query. Ortholog identification and alignment was performed in Phylophlan. A maximum-likelihood phylogeny was reconstructed from the concatenated alignments in FastTree MP (JTT + CAT) implemented in the Cipres Science Gateway Server ([@B33]). The robustness of the phylogeny was assessed using 1000 bootstrap pseudoreplicates.

Secondary Metabolite Analysis
-----------------------------

Gene clusters known to be involved in secondary metabolite biosynthesis, self-immunity, or resistance were identified using Antibiotics and Secondary Metabolite Analysis Shell (anti-SMASH) version 4.0.0 ([@B32]). The GenBank sequence file (from Prokka annotation) was submitted to the web interface selecting all extra features of annotation.

Results
=======

Isolation of *Streptomyces* From Soil
-------------------------------------

Aliquots (20 μl) of diluted soil samples were cultivated on several agars to select for *Streptomyces* including ISP2 (1/5th) and alkaline SFM (**Figure [1](#F1){ref-type="fig"}**). The original soil was returned to the sampling site as per local tradition.

![*Streptomyces* sp. myrophorea isolation from **(A)** Boho soil sample site, **(B)** selective enrichment agar, and **(C)** pure culture. **(D--I)** AFM data of *Streptomyces* sp. myrophorea, isolate McG1 grown on glass coverslips and imaged in air by Tapping Mode. Both vegetative **(D--F)** and sporulating **(G--I)** stages are shown. Hyphae overviews are shown in **D** and **G**, while higher resolution scans in **E** and **F** for vegetative hyphae, and in **H** and **I** for sporulating hyphae.](fmicb-09-02458-g001){#F1}

Preliminary screening of the Boho soil sample resulted in the isolation of eight (visually different) *Streptomyces*-like colony types as determined by colony morphology and growth characteristics. The *Streptomyces* isolate which had the most consistent inhibitory activity toward Gram-positive and Gram-negative bacteria (initially labeled as *Streptomyces* sp. myrophorea, isolate McG1) was selected for further characterization and testing (**Figure [1](#F1){ref-type="fig"}**).

*Streptomyces* Characterization
-------------------------------

Visually *Streptomyces* sp. myrophorea, isolate McG1 had (powdery) light to dark green colonies on SFM agar with green to very light green/white spores (**Figures [1B,C](#F1){ref-type="fig"}**). After a period of approximately 3--5 days, colonies emitted a distinctly "germaline" odor. *Streptomyces* sp. myrophorea, isolate McG1 appeared to be a non-motile, spore forming bacteria with very slender vegetative and aerial hyphae. Atomic force microscopy revealed that the bacterial hyphae were approximately 0.5--1.0 μm width, with spores in a linear conformation (17--20 spores) having a width of approximately 0.5--1.0 μm (**Figures [1D](#F1){ref-type="fig"}--[I](#F1){ref-type="fig"}**).

Alkaline Tolerance of *Streptomyces* sp. Myrophorea, Isolate McG1
-----------------------------------------------------------------

The Boho soil sample had an average pH of 7.8 (mean ± standard deviation 0.35, by pH meter). Parallel measurements using pH strips indicated a wider range of pH from pH 7.8 to pH 8.5 (six readings at two different time points).

To measure the pH tolerance of *Streptomyces* sp. myrophorea, isolate McG1, a pH gradient was prepared as described. The pH levels of the agar surface were measured after it had set and every subsequent day after this using flat pH sticks (see the section "Materials and Methods"). The results revealed pronounced *Streptomyces* sp. myrophorea, isolate McG1 growth around pH 9.0 to pH 10 after 3--4 days. Growth was slower when bacteria were inoculated on agar that was prepared at pH 11.5 and took 5 days to be visible, however, during this time the pH of the agar also dropped to pH 10.5 (**Figure [2A](#F2){ref-type="fig"}**). In addition, we observed that *Streptomyces* sp. myrophorea, isolate McG1 inoculated at pH 12.2 or 13.0 could survive several days without prominent growth. As above, we noted that bacterial biomass became visible once the pH of the agar decreased to pH 10.5. In contrast *S. coelicolor* M145 was unable to grow in high alkaline conditions (pH 9 and above) implying that our new strain of *Streptomyces* was more alkaliphilic.

![*Streptomyces* sp. myrophorea, isolate McG1 development on pH and irradiation gradients. **(A)** *Streptomyces* sp. myrophorea, isolate McG1 cultivated on ISP-2 agar under increasing pH. Images indicate final measurements, pH 9.0 (originally pH 9.5), pH 9.5 (originally pH 10.0), pH 10.0 (originally pH 10.7), and pH 10.5 (originally pH 11.6). Images are representative of three independent experiments. **(B)** Effect of *γ-*irradiation (^60^Co) on spore survival of *Streptomyces* sp. myrophorea, isolate McG1. All tests performed in triplicate. The variation in spore survival is indicated using standard error of the mean.](fmicb-09-02458-g002){#F2}

In contrast to the alkaline conditions, *Streptomyces* sp. myrophorea, isolate McG1 did not grow well under acidic conditions, the lowest pH for growth being pH 6.5.

Based on changes in pH during sterilization of media and between buffered and unbuffered media, we realize that it is very important to measure the pH of the agar surface throughout the bacterial growth cycle.

Radio-Tolerance of *Streptomyces* sp. Myrophorea, Isolate McG1
--------------------------------------------------------------

The alkaline environment of the Boho area is not the only characteristic which makes this region a niche habitat. The (limestone/shale) bedrock also releases radon gas which can be found at levels as high as 710 bq/m^3^ (domestic dwelling annual totals) in Boho and adjacent areas ([@B11]).

To test the effects of radiation on the survival of *Streptomyces* sp. myrophorea, isolate McG1, we subjected spore solutions to increasing levels of gamma radiation, i.e., spores were removed from a chamber after an exposure to absorbed doses of 0.25 → 20 kGy. After irradiation, aliquots (100 μl) of spores were spread evenly on diluted ISP2 agar in triplicate. The agar plates were then incubated at 4--10°C for 3 weeks before enumeration. Our measurements indicated that spores of *Streptomyces* sp. myrophorea, isolate McG1 were able to tolerate doses of 4 kGy of gamma irradiation and still remain viable (**Figure [2B](#F2){ref-type="fig"}**). In comparison, another *Streptomyces*, *Streptomyces radiopugnans* resists radiation expose of up to 15 kGy, whereas vegetative cells such as *Deinococcus radiodurans* tolerates an exposure of 12 kGy, *E. coli* 600 Gy, and human cells 4 Gy ([@B31]; [@B10]).

Antimicrobial Tests
-------------------

To test antimicrobial potential of *Streptomyces* sp. myrophorea, isolate McG1, agar cores from the *Streptomyces* were embedded in Mueller-Hinton test agar and overlaid with a suspension of ESKAPE pathogens. The pathogens were isolated from different hospitals in Croatia based on clinical antimicrobial susceptibility data. Controls consisted of ampicillin (Amp-20 μg), chloramphenicol (Cam-20 μg), ciprofloxacin (Cip-5 μg), gentamicin (Gen-30 μg), kanamycin (Kan-10 μg), streptogramin (10 μg), and ampicillin + sulbactam (Amp + Sulf-10 μg + 10 μg). An agar core from the original ISP2 supplemented agar was used as a negative control.

ESKAPE pathogens were considered susceptible (S) to antibiotics if the zone of inhibition was greater than 12 mm diameter; resistant (R), if zone was less than 8 mm radius and of intermediate status (I) if the zone was between 8 and 12 mm or there were a few colonies appearing in between the beginning of the zone and the edge of the antibiotic disc. A single mark indicates uniformity of result in a triplicate. Tests with variable results are indicated by the result of each replicate, i.e., S/R/S indicates the result of 1st/2nd/3rd test (**Table [1](#T1){ref-type="table"}**).

###### 

Inhibitory effects of *Streptomyces* sp. myrophorea, isolate McG1 against ESKAPE pathogens.

  Bacteria               *Streptomyces* sp. myrophorea, isolate McG1   Antibiotic sensitivity   
  ---------------------- --------------------------------------------- ------------------------ -----------
  *E. faecium*                                                                                  
  Strain (a)             S                                             Amp R,                   Cam S
  Strain (b)             S                                             Amp S,                   Cam R
  Strain (c) (VRE)^∗∗^   S                                             Amp R,                   Cam R
  Strain (d)±            R                                             Amp S,                   Cam S
  Strain (e)±            R                                             Amp S,                   Cam S
  Strain (f)±            R                                             Amp R,                   Cam S
  *S. aureus*                                                                                   
  Strain (a)             S                                             Amp S/S/R,               Cam S
  Strain (b) MRSA^∗∗^    S                                             Amp R,                   Cam S
  Strain (c)             S                                             Amp S,                   Cam S
  Strain (d)             S                                             Kan S,                   Cam S/S/R
  Strain (e) MRSA ^∗∗^   S                                             Amp R,                   Cam S
  *K. pneumoniae*                                                                               
  Strain (a)             S                                             Amp S,                   Cam S
  Strain (b)             S                                             Amp S,                   Cam S
  Strain (c)             S                                             Amp R,                   Cam R
  Strain (d)             S                                             Amp R,                   Cam S/R/S
  *A. baumannii*                                                                                
  Strain (a)^∗^          S                                                                      Cam R
  Strain (b)             R                                             Amp + Sul S,             Cam R
  Strain (c)             I                                             Amp + Sul R,             Cam R
  Strain (d)^∗^          S                                                                      Cam R
  Strain (e)^∗^          S                                             Amp R,                   Cam R
  *P. aeruginosa*                                                                               
  Strain (a)             I/S/I                                         Streptogramin R,         Cip S
  Strain (b)             S                                             Kan S,                   Cam R
  Strain (c)             R/S/R                                         Streptogramin R,         Cip S
  Strain 27853 ATCC      R                                             Gen S,                   Cip S
  *E. cloacae*                                                                                  
  Strain (a)             S                                             Amp R,                   Cam R
  *E. coli* K12          S                                             Amp S,                   Cam S
  *B. subtilis* 168      S                                             Amp S,                   Kan S
                                                                                                

The inhibitory effects of Streptomyces sp. myrophorea, isolate McG1 were compared to those of ampicillin (Amp-10 μg), chloramphenicol (Cam-20 μg), ciprofloxacin (Cip-5 μg), gentamicin (Gen-30 μg), kanamycin (Kan-10 μg), streptogramin: ampicillin + sulbactam (Amp + Sulf-10 μg + 10 μg)) and a negative control (an agar core from the original ISP2 supplemented agar) using the agar overlay method. ESKAPE pathogens were considered susceptible (S) to antibiotics if the zone of inhibition was greater than 12 mm diameter; resistant (R), if zone was less than 8 mm radius and of intermediate status (I) if the zone was between 8 and 12 mm or there were a few colonies appearing in between the beginning of the zone and the edge of the antibiotic disc. A single mark indicates uniformity of result in a triplicate. Tests with variable results are indicated by a sign for each replicate, i.e., S/R/S indicates the result of 1st/2nd/3rd test. Could only be cultivated on blood agar (±), WHO critical-priority bacteria (

∗

), and WHO high priority bacteria (

∗∗

).

ESKAPE pathogens are known to resist many clinical antibiotics including aminoglycosides, beta-lactams, carbapenems and glycopeptides ([@B14]). Our data on the incubation of ESKAPE pathogens reveal that *Streptomyces* sp. myrophorea, isolate McG1 was broadly inhibitory to both Gram-positive and Gram-negative bacteria. Specifically *Streptomyces* sp. myrophorea, isolate McG1 inhibited carbapenem-resistant *A. baumannii* \[listed as a critical pathogen in the WHO priority pathogens list), vancomycin-resistant *E. faecium*, and methicillin-resistant *S. aureus* (which are both listed as high priority on the WHO pathogen list)\] and *K. pneumoniae* (**Figure [3](#F3){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**). Some strains of *E. faecium* that could not be cultivated on Mueller-Hinton agar (they only grew on blood agar) as well as some strains of multi-resistant *P. aeruginosa* were resistant to *Streptomyces* sp. myrophorea, isolate McG1 (**Table [1](#T1){ref-type="table"}**).

![Inhibition of clinical strains of *S. aureus* by agar cores of *Streptomyces* sp. myrophorea, isolate McG1. *S. aureus* (SA) strains: SA strain **a**, SA strain **b** (MRSA, ciprofloxacin resistant), SA strain **c** and SA strain **e** (MRSA, ciprofloxacin sensitive) were cultivated on Mueller-Hinton agar together with agar cores of *Streptomyces* sp. myrophorea, isolate McG1 (S.m). Other test wells contained chloramphenicol (CAM-20 μg), ampicillin (AMP-20 μg), and a negative control of the original ISP-2 agar with mineral supplement (cont). Images are representative of three independent experiments.](fmicb-09-02458-g003){#F3}

Genome Sequencing of *Streptomyces* sp. Myrophorea, Isolate McG1
----------------------------------------------------------------

Whole-genome sequencing of *Streptomyces* sp. myrophorea, isolate McG1 was performed using the Illumina MiSeq system. The total assembled size of the *Streptomyces* sp. myrophorea, isolate McG1 genome was almost 9 MB pairs with a GC content of 71.6%. Parameters predicted by Prokka and QUAST ([@B16]; **Table [2](#T2){ref-type="table"}**).

###### 

*Streptomyces* sp. myrophorea, isolate McG1 genome characterization and assembly (Prokka).

  Genome characterization    Filtered
  -------------------------- -----------
  Total length (bp)          8,950,068
  Number of contigs          110
  GC content (%)             71.64
  Predicted no. of genes     7643
  Number of tRNAs            78
  Number of rRNAs            8
  N50 score                  409,278
  Number of Ns per 100 kbp   0
                             

The "Number of Ns per 100 kbp" is the average number of uncalled bases (Ns) per 100,000 assembly bases, the N50 is defined as the minimum contig length needed to cover 50% of the genome.

Deposition of Genome Sequence
-----------------------------

The genome sequence was deposited in NCBI under the name of "*Streptomyces* sp. myrophorea, isolate McG1" (TaxID 2099643) or "*Streptomyces* sp. McG1," Biosample accession number [SAMN08518548](SAMN08518548), BioProject accession number [PRJNA433829](PRJNA433829), Submission ID: [SUB3653175](SUB3653175), and Locus tag prefix: C4625. The project information is accessible on publication from <http://www.ncbi.nlm.nih.gov/bioproject/433829>.

*Streptomyces* sp. myrophorea, isolate McG1 was deposited with the National Collection of Type Cultures (NCTC 14177), United Kingdom and the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) GmbH, Germany.

DNA--DNA Hybridization
----------------------

The top 12 matches against *Streptomyces* genomes and the intergenomic distances for *in silico* DNA--DNA hybridization (DDH) were calculated using GGDC (**Table [3](#T3){ref-type="table"}**). The calculation of GGDC Formula 2 is independent of genome length (calculated by dividing found identities by high-scoring pairs and not by whole-sequence length). An absence of any DDH values over the recognized threshold of 70% revealed that our isolate was an uncharacterized species of *Streptomyces*.

###### 

The closest 12 matches to *Streptomyces* sp. myrophorea, isolate McG1 in NCBI (by GGDC) (Formula 2 statistics).

  Isolate                                                       Accession number   DDH    Prob. DDH ≥ 70%   Distance
  ------------------------------------------------------------- ------------------ ------ ----------------- ----------
  *Streptomyces anulatus* strain ATCC 11523^T^                  PRJNA257397        55.1   35.24             0.061
  *Streptomyces europaeiscabiei* strain NCPPB 4064              PRJNA255689        55.0   35.11             0.061
  *Streptomyces* sp. EN16                                       PRJNA338712        54.9   34.79             0.061
  *Streptomyces* sp. Root63                                     SAMN04155842       54.7   33.99             0.062
  *Streptomyces* sp. Root1295                                   SAMN04155717       54.5   33.31             0.062
  *Streptomyces* sp. W007                                       PRJNA74679         53.5   29.81             0.064
  *Streptomyces griseus* subsp. griseus strain NRRL B-2682^T^   SAMN05558834       52.9   27.86             0.065
  *Streptomyces* sp. OspMP-M43                                  SAMN04883176       52.6   27.01             0.066
  *Streptomyces griseus* strain NRRL B-2165^T^                  SAMN05558833       52.6   26.98             0.066
  *Streptomyces* sp. MNU77                                      SAMN03200165       51.8   24.39             0.068
  *Streptomyces griseus* subsp. griseus strain NRRL WC-3480     SAMN02645398       51.8   24.40             0.068
                                                                                                            

Alkaline and Radio Tolerance Genes
----------------------------------

The ability of bacteria such as *Streptomyces* sp. myrophorea, isolate McG1 to tolerate high levels of alkalinity is often attributed to alkaline shock genes, proton antiporters (like *nhaA*), and multidrug resistance factors (like *mdt*/*mdfA*) ([@B25]; [@B18]). We identified the presence of these genes in the annotated genomes of *Streptomyces* sp. myrophorea, isolate McG1 and *S. coelicolor* M145 listing 25 of these genes in *Streptomyces* sp. myrophorea, isolate McG1 and 9 genes in the genome of *S. coelicolor* M145 (**Table [4](#T4){ref-type="table"}**). Only *Streptomyces* sp. myrophorea, isolate McG1 possessed alkaline shock genes, aspartate/ammonium antiporters, and multidrug transporters of the type *mdtH* (**Table [4](#T4){ref-type="table"}**). Hence, the *Streptomyces* sp. was referred to as strain myrophorea, isolate McG1, from the Greek myro (fragrance; the isolate emits a strong fragrant odor) and phorea (porter/carrier; in recognition of the number of predicted antiporter genes).

###### 

List of alkaline tolerance genes identified in *Streptomyces* sp. myrophorea, isolate McG1 and *S. coelicolor* M145.

  *Streptomyces* sp. myrophorea, isolate McG1   *S. coelicolor* M145                                                      
  --------------------------------------------- ---------------------------------------------------------- -------------- ------------------------------------------
  504                                           Alkaline shock protein 23                                  HPPA_STRCO     K^+^ insensitive pyrophosphate
  6561                                          Alkaline shock protein 23                                  Q9S2Y0_STRCO   Putative Na^+^/H^+^ antiporter
  1049                                          Ammonium/H^+^ antiporter subunit *amhM*                    Q9F3L8_STRCO   Putative Na^+^/H^+^ antiporter
  2800                                          Aspartate/alanine antiporter                               Q9KYW0_STRCO   Putative Na^+^/H^+^ antiporter
  2801                                          Aspartate/alanine antiporter                               Q9XAJ9_STRCO   Putative Na^+^/H^+^ antiporter
  6218                                          Aspartate/alanine antiporter                               NHAA1_STRCO    Na^+^/H^+^ antiporter *nhaA*
  3284                                          Enhanced intracellular survival protein                    NHAA2_STRCO    Na^+^/H^+^ antiporter *nhaA2*
  159                                           K^+^/H^+^ antiporter *nhaP*                                NHAA3_STRCO    Na^+^/H^+^ antiporter *nhaA3*
  3788                                          K^+^/H^+^ antiporter *nhaP2*                               Q93JF3_STRCO   Putative integral membrane ion exchanger
  1050                                          K^+^/H^+^ antiporter *yhaU*                                               
  2193                                          K^+^/H^+^ antiporter *yhaU*                                               
  1325                                          K^+^ insensitive pyrophosphate-energized proton pump                      
  923                                           Multidrug resistance protein *mdtH*                                       
  3240                                          Multidrug resistance protein *mdtH*                                       
  3252                                          Multidrug resistance protein *mdtH*                                       
  6781                                          Multidrug resistance protein *mdtH*                                       
  1282                                          Na^+^/H^+^ antiporter *nhaA*                                              
  4210                                          Na^+^/H^+^ antiporter subunit A                                           
  4211                                          Na^+^/H^+^ antiporter subunit C                                           
  4212                                          Na^+^/H^+^ antiporter subunit D                                           
  4215                                          Na^+^/H^+^ antiporter subunit G                                           
  660                                           Na^+^/(H^+^ or K^+^) antiporter *gerN*                                    
  3425                                          Na^+^/(H^+^ or K^+^) antiporter *gerN*                                    
  7210                                          Putative Na^+^/H^+^ exchanger                                             
  1727                                          Sodium, potassium, lithium, and rubidium/H^+^ antiporter                  
                                                                                                                          

A similar identification of the number of DNA repair genes for *Streptomyces* sp. myrophorea, isolate McG1, and *S. coelicolor* M145 revealed little difference (**Supplementary Table [S2](#SM2){ref-type="supplementary-material"}**).

Phylogeny
---------

To infer the evolutionary history of *Streptomyces* sp. myrophorea, isolate McG1 a maximum-likelihood phylogeny was performed using a concatenation of 400 protein sequences (**Figure [4](#F4){ref-type="fig"}**).

![Maximum-likelihood phylogenetic tree of *Streptomyces* sp. myrophorea, isolate McG1. Tree shows the phylogenetic relationships between the closest GGDC matches; constructed with PhyloPhlAn. The phylogenetic tree was drawn in Fasttree from a concatenated alignment of 400 protein sequences in PhyloPhlAn. Numbers at nodes represent bootstrap values.](fmicb-09-02458-g004){#F4}

Identification of Secondary Metabolites
---------------------------------------

Potential antibiotic synthesis clusters from *Streptomyces* sp. myrophorea, isolate McG1 were predicted using anti-SMASH ([@B1]). This revealed that *Streptomyces* sp. myrophorea, isolate McG1 possessed a total of 45 secondary metabolite biosynthesis gene clusters including multiple clusters with genes encoding the following secondary metabolite families: non-ribosomal peptide synthetase (NRPS) -- 5 clusters; type I polyketide synthase (TI PKS) -- 10 clusters; type III polyketide synthase (TIII PKS) -- 2 clusters; terpenes -- 5 clusters, lantipeptides -- 3 clusters, and other biosynthesis genes clusters (BGCs) (**Table [5](#T5){ref-type="table"}**).

###### 

The distribution of biosynthesis gene clusters in the *Streptomyces* sp. myrophorea, isolate McG1.

  Gene type                            From     To       Biosynthetic gene cluster (BGC)
  ------------------------------------ -------- -------- ------------------------------------------------
  Aminoglycoside                       211467   235061   Streptomycin BGC (19%)
  Bacteriocin                          60075    71379    --
  Bacteriocin                          58414    69211    Tetronasin BGC (3%)
  Butyrolactone                        86467    97372    Coelimycin BGC (8%)
  Ectoine                              67460    77858    Ectoine BGC (100%)
  Ladderane-Arylpolyene-NRPS           171438   299095   Skyllamycin BGC (46%)
  Lantipeptide                         97251    120571   --
  Lantipeptide                         49038    71665    AmfS BGC (100%)
  Melanin                              98889    109311   Melanin BGC (100%)
  Melanin                              466637   477122   Melanin BGC (100%)
  NRPS                                 121282   183145   Arixanthomycin BGC (5%)
  NRPS                                 45983    133910   Coelichelin_BGC (90%)
  NRPS                                 139743   190212   Griseoviridin\_/\_viridogrisein_BGC (5%)
  NRPS                                 105944   148690   A54145_BGC (3%)
  NRPS                                 1        38617    Friulimicin BGC (12%)
  Other KS                             103777   144736   Salinilactam BGC (8%)
  Siderophore                          55548    70283    --
  Siderophore                          8280     20058    Desferrioxamine B BGC (100%)
  TI PKS                               244352   272539   Kirromycin BGC (5%)
  TI PKS                               27526    57767    Nystatin-like pseudonocardia polyene BGC (26%)
  TI PKS                               1        9188     --
  TI PKS                               1        7809     Piericidin A1 BGC (50%)
  TI PKS                               1        42606    Kendomycin BGC (25%)
  TI PKS                               1        5761     Cremimycin BGC (17%)
  TI PKS                               1        7661     Nanchangmycin BGC (30%)
  TI PKS                               1        5579     --
  TI PKS                               1        22496    Piericidin A1 BGC (50%)
  TI PKS                               595702   666824   Lidamycin BGC (41%)
  TI PKS-Linaridin                     1        37834    Cypemycin BGC (77%)
  TI PKS-NRPS                          212061   264613   Daptomycin BGC (7%)
  TI PKS-NRPS                          8668     63347    Enduracidin BGC (8%)
  TI PKS-NRPS                          483977   533453   SGR_PTMs BGC (100%)
  TI PKS-other KS                      86013    144228   Borrelidin BGC (18%)
  TIII PKS                             201579   242697   Herboxidiene BGC (6%)
  TIII PKS                             509840   550892   Alkylresorcinol\_ BGC (100%)
  Terpene                              51484    72797    2-Methylisoborneol BGC (100%)
  Terpene                              33012    55225    --
  Terpene                              309196   335766   Hopene BGC (69%)
  Terpene                              314534   335541   --
  Terpene-NRPS                         362776   437437   Isorenieratene BGC (100%)
  Terpene-TI-PKS                       1        44677    BE-7585A BGC (23%)
  Thiopeptide                          5614     38302    --
  Trans-AT-PKS-other KS                40047    120375   Daptomycin BGC (6% )
  Trans AT-PKS-TI PKS-Other KS, NRPS   356818   421396   --
                                                         

Biosynthesis gene clusters (%, indicates the proportion of genes showing similarity). TI PKS, Type I polyketide synthase; TIII PKS, Type III polyketide synthase; transAT-PKS, trans-amino transferase polyketide synthase; NRPS, non-ribosomal synthesized peptide; other KS, other ketide synthases.

*Streptomyces* sp. Myrophorea, Isolate McG1 Resistance to Antibiotics
---------------------------------------------------------------------

Antibiotic producing bacteria such as *Streptomyces* often require resistance genes to ameliorate the potentially toxic nature of their secondary metabolites. Such resistance elements can also be associated with antimicrobial biosynthesis gene clusters and can be used to predict potential antimicrobial synthesis ([@B37]). To better characterize these resistance elements, we cultivated *Streptomyces* sp. myrophorea, isolate McG1 in the presence of 36 different antibiotics (in triplicate). *Streptomyces* sp. myrophorea, isolate McG1 was resistant to 20 out of the 36 antibiotics tested after 2 days growth (**Table [6](#T6){ref-type="table"}** and **Figure [5A](#F5){ref-type="fig"}**). Resistance to a further eight antibiotics was visually apparent after a further 4 days, most notably in vancomycin, produced by *Amycolatopsis orientalis*; imipenim, a β-lactam stablized version of thienamycin, produced by *Streptomyces cattleya* and erythromycin, a macrolide antibiotic produced by *Saccharopolyspora erythraea* (**Figure [5B](#F5){ref-type="fig"}**).

###### 

Antibiogram of *Streptomyces* sp. myrophorea, isolate McG1.

  Antibiotic                        Amt (μg)   2 days   6 days
  --------------------------------- ---------- -------- --------
  Amikacin                          30         S        S
  Ampicillin                        20         R        R
  Ampicillin + sulbactam            20         R        R
  Augmentin                         30         S        R
  Apromycin                         20         S        R
  Carbenicillin                     20         R        R
  Cefepime                          30         R        R
  Ceftazidime                       10         R        R
  Ceftibuten                        30         R        R
  Cefoxitin                         30         R        R
  Ceftriaxone                       30         R        R
  Cefuroxime                        30         R        R
  Cefurin                           5          R        R
  Ciprofloxacin                     5          I        R
  Clavuranic acid                   10         R        R
  Ertapenem                         10         R        R
  Erythromycin                      15         I        I
  Gentamicin                        10         S        S
  Imipenem                          10         S        R
  Kanamycin                         20         S        R
  Linezolid                         10         S        I
  Meropenem                         10         I        R
  Mupiricin                         200        R        R
  Netilmicin                        10         S        S
  Nitrofurantoin                    100        R        R
  Novobiocin                        5          S        R
  Piperacillin + tazobactam         36         R        R
  Quinpristin + dalropristin        5          R        R
  Rifampicin                        5          S        R
  Streptomycin                      20         R        R
  Tigecycline                       15         S        R
  Tetracycline                      20         R        R
  Trimethoprim + sulfamethoxazole   25         R        R
  Vancomycin                        5          S        R
                                                        

Streptomyces sp. myrophorea, isolate McG1 was cultivated with clinical antibiotics. An inhibitory zone greater than 12 mm diameter was considered sensitive (S) to these antibiotics, a zone between 12 and 8 mm or a few colonies scattered in the inhibition zone was considered intermediate (I) and a zone of 8 mm diameter or less was considered resistant (R).

![Antibiogram of *Streptomyces* sp. myrophorea, isolate McG1. **(A)** *Streptomyces* sp. myrophorea, isolate McG1 cultivated on ISP-2 agar (6 days) in the presence of an array of clinical antibiotics starting at the top the image and moving clockwise: imipenem (IMI 10), ertapenem (ETP 10), linezolid (LZD 10), quinpristin + dalropristin (SYN 15), erythromycin (E 15) and meropenem (MEM 10). **(B)** Delayed development of antibiotic resistance in *Streptomyces* sp. myrophorea, isolate McG1 only became apparent for some antibiotics after 6 days incubation in the case of erythromycin (E-15 μg), imipenem (IMI-10 μg), and vancomycin (VA-5 μg). The full antibiogram list is available in **Table [6](#T6){ref-type="table"}**.](fmicb-09-02458-g005){#F5}

*In silico* Prediction of Antibiotic-Resistance Genes (ARGs) in *Streptomyces* sp. Myrophorea, Isolate McG1
-----------------------------------------------------------------------------------------------------------

Antibiotic resistance gene clusters for *Streptomyces* sp. myrophorea, isolate McG1 were predicted *in silico* using anti-SMASH. Many copies of multiple antibiotic resistance elements were also predicted through RAST including β-lactamases (classes A and C), metal-dependant hydrolase of β-lactams (metallo β-lactamase L1), β-lactamase (cephalosporinase), and other penicillin binding proteins (**Supplementary Table [S3](#SM3){ref-type="supplementary-material"}**). In addition many metal resistance elements were identified (through RAST) to mercury, copper, cobalt, zinc/cadmium, and arsenic which have been linked to increased antibacterial resistance ([@B9]) (**Supplementary Table [S3](#SM3){ref-type="supplementary-material"}**). It is also possible that resistance may also be mediated through other mechanisms such as general multi-resistance clusters.

Discussion
==========

We have isolated a novel species of *Streptomyces* from an alkaline/radon environment that inhibits the growth of many multiresistant ESKAPE pathogens. There have been several reports in recent years of the presence of *Streptomyces* and other organisms in alkaline environments that can tolerate high pH levels ([@B48]; [@B51]; [@B20]; [@B30]). Our original hypothesis presumed that the Boho soil sample most likely contained *Streptomyces* which may produce antibiotics given the alkaline nature of the environment ([@B24]). However, we were surprised to find that our isolate, *Streptomyces* sp. myrophorea, isolate McG1 inhibited the growth of many of the multiresistant ESKAPE pathogens. Some of these bacteria have been listed in a recent WHO document on priority pathogens urgently requiring the development of new antibiotics, such as carbapenem-resistant *A. baumannii* (at the top of this list) classified as a critical priority pathogen and vancomycin-resistant *Enterobacter faecium* and methicillin-resistant *S. aureus* classified as high priority pathogens ([@B47]).

We have not ascertained the active component(s) responsible for inhibition of ESKAPE pathogens by *Streptomyces* sp. myrophorea, isolate McG1 as yet but this forms part of our ongoing research. Many *Streptomyces* species have the capacity to produce multiple antibiotics whose composition and identity can vary from species to species ([@B49]; [@B40]). Given that our isolate encodes many antimicrobial gene clusters, it is entirely possible that some of these are responsible for the inhibition of ESKAPE pathogens. Given that our species is also novel and has the capacity to inhibit many multi-resistant pathogens also raises the possibility that some of its inhibitory components could be novel.

Another unexpected finding of the research was that although the pH of the Boho soil sample was around pH 8; our species of *Streptomyces* was able to grow at pH 10.5. This suggested not only tolerance of high alkaline conditions but the capacity to grow and divide in an extreme environments. More detailed tests will have to be made to ascertain the specifics of these optimal growth conditions.

The mechanism by which organisms such as *Streptomyces* can ameliorate high alkaline conditions is thought to be a product of a group of pH homeostasis genes, some of which have been identified in other species as alkaline shock genes, multidrug resistance factors (*mdt*/*mdfA*) and proton antiporters (*nhaA*) ([@B25]; [@B18]). Alkaline tolerance is also linked to the production of antibiotics through the presence of multidrug resistance factors which are often associated with antimicrobial biosynthesis gene clusters ([@B37]).

In support of our results, genome sequencing of *Streptomyces* sp. myrophorea, isolate McG1 revealed that it contained more annotated alkaline tolerance genes than *S. coelicolor* M145 (at 25/9). Furthermore alkaline shock genes, ammonium and aspartate antiporters and multidrug resistance antiporters of the type *mdt*H were only identified in the *Streptomyces* sp. myrophorea, isolate McG1 genome and not in *S. coelicolor* M145 genome. Indeed, it was this abundance of porters and the fragrant smell of the *Streptomyces* that prompted us to refer to the strain as myrophorea, isolate McG1, myro (Greek for fragrance) and phorea (Greek for porter).

The sequencing of the *Streptomyces* sp. myrophorea, isolate McG1 genome also enabled the prediction of potential antibiotics through anti-Smash and RAST ([@B3]; [@B32]). However, given the cryptic nature of many *Streptomyces* spp. metabolites, it cannot be assumed these antibiotics are produced until their products are identified. We were also able to predict many antibiotic resistance clusters through RAST which are often associated with antimicrobial biosynthesis gene clusters ([@B37]). Antimicrobial resistance predictions were followed by *in vitro* experiments on 36 clinical antibiotics. This data showed that *Streptomyces* sp. myrophorea, isolate McG1 was resistant to 28 out of 36 antibiotics. Specifically it was resistant to nearly all the β-lactams, with the exception of augmentin to which resistance developed after 6 days. The same pattern of delayed resistance was seen for glycopeptides, fluoroquinones (such as ciprofloxacin), and tetracyclines (such as tigecycline).

It is interesting that the ancient healers of Boho made a connection between alkaline soils (containing *Streptomyces* sp.) and (skin) infections. It has only recently been discovered that the pH of the specific infection sites can rise from normal skin pH about pH 5.5 to 8.5 and that bacterial biofilms, which can colonize wounds, can also reach similar pH levels ([@B44]; [@B19]; [@B39]). Perhaps the indigenous people, who were undoubtedly in close proximity to the soil, noted (after many years) its curative properties under specific conditions. However, it is difficult to know the exact genesis of this cure because the previous occupants of the Boho site, the Druids, left no surviving records of healing and their Neolithic counterparts left only undeciphered carvings on some nearby stones. Anthropologically, the Boho folk tradition is similar to that of Kisameet Bay clay in Canada, another indigenous soil cure which was found to have inhibitory activity against a range of ESKAPE pathogens ([@B6]).

Conclusion
==========

We have isolated and genome sequenced a novel alkaline and radio-tolerant species of *Streptomyces* from an ethnopharmacological soil cure; *Streptomyces* sp. myrophorea, isolate McG1. This *Streptomyces* sp. inhibits many multi-resistant ESKAPE pathogens including carbapenem-resistant *A. baumannii* (a critical priority species from the WHO priority list of antibiotic-resistant bacteria), vancomycin-resistant *E. faecium*, and methicillin-resistant *S. aureus* (listed as high priority by the WHO). Although not a complete elucidation of the antibacterial components of the Boho soil; we think that inhibition of such pathogens by *Streptomyces* sp. myrophorea, isolate McG1 may explain some of its reputed curative properties. It is hoped to further characterize some of these inhibitory components from *Streptomyces* sp. myrophorea, isolate McG1 and investigate the properties of other species contained in alkaline soil. We hope this will advance progress in stemming the tide of multi-resistant bacteria.
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